Literature DB >> 12427876

Amount and type of alcohol and risk of dementia: the Copenhagen City Heart Study.

Thomas Truelsen1, Dorte Thudium, Morten Grønbaek.   

Abstract

OBJECTIVE: To assess whether amount or type of alcohol is associated with risk of dementia. METHODS AND
SUBJECTS: Case-control nested in a cohort study among participants in the third Copenhagen City Heart Study (1991 to 1994), aged 65 years or more, who where screened using the Mini-Mental State Examination and subsequently examined for dementia. There were 83 subjects diagnosed with dementia and the remaining 1,626 nondemented subjects were included as controls. The two groups were compared with regard to alcohol intake and type of alcohol assessed 15 years before.
RESULTS: Average weekly total alcohol intake had no significant effect on risk of dementia. Monthly and weekly intake of wine was significantly associated with a lower risk of dementia. For beer and spirits, only a monthly intake of beer was significantly associated with an increased risk of dementia. The effect of alcohol on risk of dementia did not differ between men and women.
CONCLUSIONS: Monthly and weekly intake of wine is associated with a lower risk of dementia. The results do not indicate that people should start drinking or increase wine consumption to avoid dementia, but instead suggest that certain substances in wine may reduce the occurrence of dementia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12427876     DOI: 10.1212/01.wnl.0000031421.50369.e7

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  72 in total

Review 1.  Cardiovascular risk factors and Alzheimer's disease.

Authors:  José A Luchsinger; Richard Mayeux
Journal:  Curr Atheroscler Rep       Date:  2004-07       Impact factor: 5.113

Review 2.  Neuronutrition and Alzheimer's disease.

Authors:  Balenahalli N Ramesh; T S Sathyanarayana Rao; Annamalai Prakasam; Kumar Sambamurti; K S Jagannatha Rao
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Adherence to a Mediterranean-type dietary pattern and cognitive decline in a community population.

Authors:  Christine C Tangney; Mary J Kwasny; Hong Li; Robert S Wilson; Denis A Evans; Martha Clare Morris
Journal:  Am J Clin Nutr       Date:  2010-12-22       Impact factor: 7.045

4.  Vegetables, unsaturated fats, moderate alcohol intake, and mild cognitive impairment.

Authors:  Rosebud O Roberts; Yonas E Geda; James R Cerhan; David S Knopman; Ruth H Cha; Teresa J H Christianson; V Shane Pankratz; Robert J Ivnik; Bradley F Boeve; Helen M O'Connor; Ronald C Petersen
Journal:  Dement Geriatr Cogn Disord       Date:  2010-05-22       Impact factor: 2.959

5.  Pomegranate polyphenols and resveratrol protect the neonatal brain against hypoxic-ischemic injury.

Authors:  Tim West; Madeliene Atzeva; David M Holtzman
Journal:  Dev Neurosci       Date:  2007       Impact factor: 2.984

Review 6.  Diet and Alzheimer's disease.

Authors:  José A Luchsinger; James M Noble; Nikolaos Scarmeas
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

Review 7.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

8.  Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease.

Authors:  Lap Ho; Mario G Ferruzzi; Elsa M Janle; Jun Wang; Bing Gong; Tzu-Ying Chen; Jessica Lobo; Bruce Cooper; Qing Li Wu; Stephen T Talcott; Susan S Percival; James E Simon; Giulio Maria Pasinetti
Journal:  FASEB J       Date:  2012-10-24       Impact factor: 5.191

9.  Effects of grape seed-derived polyphenols on amyloid beta-protein self-assembly and cytotoxicity.

Authors:  Kenjiro Ono; Margaret M Condron; Lap Ho; Jun Wang; Wei Zhao; Giulio M Pasinetti; David B Teplow
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

10.  AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism.

Authors:  Valérie Vingtdeux; Luca Giliberto; Haitian Zhao; Pallavi Chandakkar; Qingli Wu; James E Simon; Elsa M Janle; Jessica Lobo; Mario G Ferruzzi; Peter Davies; Philippe Marambaud
Journal:  J Biol Chem       Date:  2010-01-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.